QB3 Symposium: Systemic Health Regulated by the Ovarian Pacemaker

​While often discussed through the lens of fertility and menopause, the ovaries play a much broader role in regulating whole-body health—shaping metabolism, cardiovascular function, bone density, immune regulation, and brain aging. This becomes especially clear after menopause, when the risks for age-related diseases — including cardiovascular disease, dementia, osteoporosis, and metabolic diseases — rise significantly.

Yet we still lack a complete understanding of what drives ovarian aging and how it contributes to systemic decline. Hormone therapy remains the primary clinical option, but innovation has been limited for decades. This is a major opportunity for new diagnostics and treatments that target the ovaries themselves.

Advances in single-cell and spatial sequencing, organoid and model systems, and clinical studies are now accelerating progress, revealing new paths for early intervention and therapeutic development. This convergence of scientific opportunity and unmet need inspired QB3 to focus this year’s symposium on ovarian health and the systemic consequences of ovarian aging.

​Learn more on the event webpage.

​Audience: We are bringing together industry and academic scientists; potential funders; and companies, from startups to big pharma, committed to the mission of understanding ovarian health and its impact on systemic health over time.